JP2009539875A5 - - Google Patents

Download PDF

Info

Publication number
JP2009539875A5
JP2009539875A5 JP2009514544A JP2009514544A JP2009539875A5 JP 2009539875 A5 JP2009539875 A5 JP 2009539875A5 JP 2009514544 A JP2009514544 A JP 2009514544A JP 2009514544 A JP2009514544 A JP 2009514544A JP 2009539875 A5 JP2009539875 A5 JP 2009539875A5
Authority
JP
Japan
Prior art keywords
phenyl
chloro
methoxy
thieno
hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009514544A
Other languages
English (en)
Japanese (ja)
Other versions
JP5198439B2 (ja
JP2009539875A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/070662 external-priority patent/WO2007146758A2/en
Publication of JP2009539875A publication Critical patent/JP2009539875A/ja
Publication of JP2009539875A5 publication Critical patent/JP2009539875A5/ja
Application granted granted Critical
Publication of JP5198439B2 publication Critical patent/JP5198439B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009514544A 2006-06-08 2007-06-08 新規なmch受容体アンタゴニスト Expired - Fee Related JP5198439B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81184106P 2006-06-08 2006-06-08
US60/811,841 2006-06-08
PCT/US2007/070662 WO2007146758A2 (en) 2006-06-08 2007-06-08 Novel mch receptor antagonists

Publications (3)

Publication Number Publication Date
JP2009539875A JP2009539875A (ja) 2009-11-19
JP2009539875A5 true JP2009539875A5 (cg-RX-API-DMAC7.html) 2010-07-22
JP5198439B2 JP5198439B2 (ja) 2013-05-15

Family

ID=38651254

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009514544A Expired - Fee Related JP5198439B2 (ja) 2006-06-08 2007-06-08 新規なmch受容体アンタゴニスト

Country Status (10)

Country Link
US (2) US8263772B2 (cg-RX-API-DMAC7.html)
EP (1) EP2029609A2 (cg-RX-API-DMAC7.html)
JP (1) JP5198439B2 (cg-RX-API-DMAC7.html)
CN (1) CN101454328A (cg-RX-API-DMAC7.html)
AU (1) AU2007257922A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0712680A2 (cg-RX-API-DMAC7.html)
CA (1) CA2652385A1 (cg-RX-API-DMAC7.html)
EA (1) EA015127B1 (cg-RX-API-DMAC7.html)
MX (1) MX2008015662A (cg-RX-API-DMAC7.html)
WO (1) WO2007146758A2 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102264737A (zh) * 2008-12-23 2011-11-30 雅培制药有限公司 抗病毒化合物
RU2505539C2 (ru) 2008-12-23 2014-01-27 Эбботт Лэборетриз Антивирусные соединения
BRPI0923527A2 (pt) 2008-12-24 2016-08-09 Syngenta Ltd métodos de preparo de fungicidas
WO2010120935A1 (en) * 2009-04-15 2010-10-21 Abbott Laboratories Anti-viral compounds
US9394279B2 (en) 2009-06-11 2016-07-19 Abbvie Inc. Anti-viral compounds
US8937150B2 (en) 2009-06-11 2015-01-20 Abbvie Inc. Anti-viral compounds
US8716454B2 (en) 2009-06-11 2014-05-06 Abbvie Inc. Solid compositions
EP2853531A3 (en) * 2009-06-11 2015-08-12 AbbVie Bahamas Ltd. Antiviral compounds
NZ605440A (en) 2010-06-10 2014-05-30 Abbvie Bahamas Ltd Solid compositions comprising an hcv inhibitor
US10201584B1 (en) 2011-05-17 2019-02-12 Abbvie Inc. Compositions and methods for treating HCV
US9034832B2 (en) 2011-12-29 2015-05-19 Abbvie Inc. Solid compositions
US20150065343A1 (en) 2012-04-02 2015-03-05 Basf Se Acrylamide compounds for combating invertebrate pests
BR112014027133A2 (pt) 2012-05-09 2017-06-27 Basf Se compostos, composição agrícola ou veterinária, método para o controle das pragas de invertebrados, material de propagação dos vegetais e método para o tratamento ou proteção de um animal.
PT2970205T (pt) 2013-03-14 2019-08-26 Tolero Pharmaceuticals Inc Inibidores da jak2 e da alk2 e métodos para a sua utilização
US11484534B2 (en) 2013-03-14 2022-11-01 Abbvie Inc. Methods for treating HCV
WO2015103490A1 (en) 2014-01-03 2015-07-09 Abbvie, Inc. Solid antiviral dosage forms
AR102849A1 (es) * 2015-03-09 2017-03-29 Astellas Pharma Inc Compuesto de piridina bicíclica
PE20180572A1 (es) 2015-06-18 2018-04-04 Cephalon Inc Derivados de piperidina 1,4-sustituidos
EP3310773B1 (en) 2015-06-18 2020-12-02 89Bio Ltd. Substituted 4-benzyl and 4-benzoyl piperidine derivatives
KR20210038906A (ko) 2018-07-26 2021-04-08 스미토모 다이니폰 파마 온콜로지, 인크. 비정상적 acvr1 발현과 연관된 질환을 치료하는 방법 및 그에 사용하기 위한 acvr1 억제제
EP3873474A4 (en) 2018-10-30 2022-07-13 Nuvation Bio Inc. HETEROCYCLIC COMPOUNDS USED AS BET INHIBITORS
JP7465945B2 (ja) * 2019-07-02 2024-04-11 ニューベイション・バイオ・インコーポレイテッド Bet阻害剤としてのヘテロ環式化合物
WO2024020034A1 (en) * 2022-07-20 2024-01-25 Arcus Biosciences, Inc. Cbl-b inhibitors and methods of use thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002003370A (ja) * 1999-09-20 2002-01-09 Takeda Chem Ind Ltd メラニン凝集ホルモン拮抗剤
US20020099073A1 (en) * 2000-07-07 2002-07-25 Andersen Henrik Sune Modulators of protein tyrosine phosphatases (PTPases)
GB0124627D0 (en) * 2001-10-15 2001-12-05 Smithkline Beecham Plc Novel compounds
US20060194871A1 (en) * 2003-04-11 2006-08-31 Barvian Kevin K Heterocyclic mchr1 antagoists
JP2007509158A (ja) * 2003-10-23 2007-04-12 グラクソ グループ リミテッド 肥満、糖尿病、うつ病及び不安を治療するためのmchr1アンタゴニストとしての3−(4−アミノフェニル)チエノピリミド−4−オン誘導体
WO2005047293A1 (en) 2003-11-07 2005-05-26 Neurocrine Biosciences, Inc. Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
BRPI0507629A (pt) * 2004-02-13 2007-07-03 Banyu Pharma Co Ltd composto, antagonista do receptor e agonista inverso do receptor da histamina h3, agente profilático ou terapêutico para uma doença metabólica, uma doença circulatória ou uma doença do sistema nervoso, ou um seu sal farmaceuticamente aceitável
US20050256124A1 (en) * 2004-04-15 2005-11-17 Neurocrine Biosciences, Inc. Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
BRPI0512252A (pt) 2004-06-18 2008-02-19 Biolipox Ab composto ou um sal farmaceuticamente aceitável do mesmo, formulação farmacêutica, uso de um composto, método de tratamento de uma doença, produto combinado, e, processo para a preparação de um composto
ATE446962T1 (de) * 2004-12-17 2009-11-15 Lilly Co Eli Thiazolopyridinon-derivate als mch- rezeptorantagonisten
CA2636617A1 (en) * 2006-02-15 2007-08-23 Lothar Schwink Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
RU2008136898A (ru) * 2006-02-15 2010-03-20 Санофи-Авентис (Fr) Азациклил-замещенные арилдигидроизохинолиноны, способ их получения и их применение в качестве лекарственных средств

Similar Documents

Publication Publication Date Title
US11485745B2 (en) Amido spirocyclic amide and sulfonamide derivatives
ES2985528T3 (es) Nuevos compuestos y composiciones farmacéuticas de los mismos para el tratamiento de enfermedades
FI3932919T3 (fi) Jak-inhibiittoriyhdiste ja sen käyttö
ES2441017T3 (es) Compuesto de pirazolo[1,5-A]pirimidina como antagonista del receptor CB1
ES2993440T3 (en) Heterocyclic derivatives and use thereof
US12606554B2 (en) Compounds and pharmaceutical compositions thereof for the treatment of diseases
JP2013523889A5 (cg-RX-API-DMAC7.html)
SI1539753T1 (sl) Spojine pirazolo(3,4-B)piridina in njihova uporaba kot inhibitorji fosfodiesteraze
WO2005117890A3 (en) Thienopyrimidines and thiazolopyrimidines for use in medicine
JP2004520324A5 (cg-RX-API-DMAC7.html)
CA2650290A1 (en) Pharmaceutical compounds
WO2000047558A1 (en) Amide compounds and medicinal use thereof
NZ553886A (en) Piperidinylamino-thieno[2,3-D] pyrimidine compounds
JP2013539789A5 (cg-RX-API-DMAC7.html)
WO2013127266A1 (en) Amido-benzyl sulfone and sulfoxide derivatives
RU2612251C2 (ru) Соединения диоксин- и оксазин[2,3-d]пиримидина в качестве ингибиторов фосфоинозитид-3-киназы и способы их применения
HRP20160725T1 (hr) Biciklični heterociklični derivati kao inhibitori fgfr kinaze za primjenu u terapiji
JP2015524450A5 (cg-RX-API-DMAC7.html)
IL305843B1 (en) Colony stimulating factor-1 receptor (csf-1r) inhibitors
JP2010532387A5 (cg-RX-API-DMAC7.html)
JP2017531672A5 (cg-RX-API-DMAC7.html)
JP2010513292A5 (cg-RX-API-DMAC7.html)
JP2008517913A5 (cg-RX-API-DMAC7.html)
RU2014131367A (ru) Соединения тиенопиримидина
JP2018525377A5 (cg-RX-API-DMAC7.html)